Page last updated: 2024-11-04
sulfasalazine and Infections, Coronavirus
sulfasalazine has been researched along with Infections, Coronavirus in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "The impact of Coronavirus disease 2019 (COVID-19) on patients with inflammatory bowel disease (IBD) is unknown." | 1.56 | Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. ( Brenner, EJ; Colombel, JF; Gearry, RB; Kaplan, GG; Kappelman, MD; Kissous-Hunt, M; Lewis, JD; Ng, SC; Rahier, JF; Reinisch, W; Ruemmele, FM; Steinwurz, F; Underwood, FE; Ungaro, RC; Zhang, X, 2020) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Brenner, EJ | 1 |
| Ungaro, RC | 1 |
| Gearry, RB | 1 |
| Kaplan, GG | 1 |
| Kissous-Hunt, M | 1 |
| Lewis, JD | 1 |
| Ng, SC | 1 |
| Rahier, JF | 1 |
| Reinisch, W | 1 |
| Ruemmele, FM | 1 |
| Steinwurz, F | 1 |
| Underwood, FE | 1 |
| Zhang, X | 1 |
| Colombel, JF | 1 |
| Kappelman, MD | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Monitoring Serologic Response to SARS-COV-2 / Coronavirus Disease 2019 (COVID-19) in Children, Adolescents, and Young Adults Receiving Biologic Therapies (RECONN)[NCT04838834] | | 472 participants (Actual) | Observational | 2020-05-15 | Active, not recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for sulfasalazine and Infections, Coronavirus